Company Search:
Advanced Search
Sponsored Links
Critical Outcome Technologies Inc. Company Snapshot
Critical Outcome Technologies Inc. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Critical Outcome Technologies Inc. with three other miscellaneous service companies in North America: Abattis Bioceuticals Corp (2013 sales of 17,448.00 Canadian Dollars [US$13,011.15 ] ), Promis Neurosciences Inc (49,516.00 Canadian Dollars [US$36,924.58 ] of which 100% was Research and Development), and American Cryostem Corp which is based in the United States ($11,529.00 of which 100% was Cell Therapy).

Sales Analysis.
  Stock Performance Chart for Critical Outcome Technologies Inc.
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): .33
(Figures in Canadian Dollars)
1 Week 6.5%   13 Weeks -13.2%  
4 Weeks -41.1%   52 Weeks -40.0%  
Critical Outcome Technologies Inc. Key Data:
  Ticker: COT Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2013 Sales 30,588
(Year Ending Jan 2014).
Employees: 10
  Currency: Canadian Dollars Market Cap: 49,222,284
  Fiscal Yr Ends: April Shares Outstanding: 149,158,435
  Share Type: Closely Held Shares: 17,982,766
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.